Business leaders in Canada say they are backing the government's planfor a national Pharmacare system because it would take drug program management away from them.
Vic Clive, assistant vice president of benefits at Canada Trust, told a conference that "it doesn't make sense" for bankers and manufacturers to manage drug programs, but they are willing to continue paying their share of the drugs bill. "We think there is enough money in the system to finance a universal drug program, including people who aren't covered, by introducing efficiency," he said.
Quebec Generic Plan Meantime the Quebec government has drawn up a plan with the province's general practitioners and pharmacists, allowing them to avoid income cuts of C$30 million ($28.4 million) a year by encouraging increased use of generics.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze